Saturday 17 October 2026 Export VVOS’s income statement to Excel — free account

Vivos Therapeutics, Inc.

Vivos Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $17.4 million, up 16.0% from fiscal 2024. In the quarter to June 2026, revenue grew 34.9%, EPS grew 43.6%, free cash flow grew 16.4% and total debt rose 2.79%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

0.13 0.01 −7.14%

Follow VVOS

Alert me

Market cap: $4.8M
P/E: 0.0×
Fwd P/E: −0.5×
Dividend yield: —
F-score: 2/9
Altman Z: −9.08
Beneish M: −1.44
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	2	2	2	4
ROE Full definition →		(335.47%)	(661.15%)	(1,470.75%)	10,022.05%
ROA Full definition →		(83.45%)	(104.71%)	(137.58%)	(101.46%)
ROIC Full definition →		(124.97%)	(237.15%)	(325.33%)	(592.70%)
Return on Tangible Assets Full definition →		(428.56%)	213.09%	260.51%	203.06%
Average Days of Receivables Full definition →		44.98	33.08	33.00	25.11
Free Cash Flow per Share Full definition →		(1.40)	(1.71)	(1.35)	(1.08)
Free Cash Flow Full definition →		(15.37)	(17.60)	(19.71)	(19.01)
Capital Expenditures Full definition →		(0.97)	(2.34)	(2.24)	(1.88)
Other line items
Cash ROIC Full definition →		(107.18%)	(189.27%)	(230.30%)	(320.84%)
Accounts Receivable Turnover Full definition →		13.38	17.35	15.74	13.61
Accounts Payable Turnover Full definition →		4.82	4.97	4.67	3.38
Inventory Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		100.16	88.80	97.45	134.98
Days of Inventory on Hand Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		144.16%	166.98%	169.14%	161.22%
Share Based Compensation of Revenue Full definition →		3.90%	3.79%	5.16%	4.25%
Operating CF/Net income Full definition →		0.84	0.72	0.70	0.67
Depreciation/Fixed assets Full definition →		0.18	0.35	0.45	0.49
Capex/Depreciation Full definition →		(0.96)	(1.79)	(1.41)	(1.05)
Revenue per Share Full definition →		1.58	1.70	1.34	1.18
Operating CF per Share Full definition →		(1.31)	(1.49)	(1.19)	(0.97)
Capex per Share Full definition →		(0.09)	(0.23)	(0.15)	(0.11)
Capex to Sales Full definition →		0.06	0.13	0.11	0.09

Show all line items

Columns are period end dates

Stockrow Weekly